# DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients

> **NCT06406439** · NA · COMPLETED · sponsor: **G2e Co., Ltd** · enrollment: 120 (actual)

## Conditions studied

- Diabetes (Insulin-requiring, Type 1 or Type 2)
- Pancreatogenic Diabetes Mellitus

## Interventions

- **DEVICE:** Smart Insulin Pen
- **DEVICE:** Injection of bolus insulin via conventional therapy using insulin pen

## Key facts

- **NCT ID:** NCT06406439
- **Lead sponsor:** G2e Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-21
- **Primary completion:** 2025-04-02
- **Final completion:** 2025-04-02
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06406439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06406439, "DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT06406439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*